Cleared Face News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cleared Face. Real-time updates on events, politics, business and more.

Up to 73% of Atopic Dermatitis Patients Taking Lilly's Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

May 1, 2023

/PRNewswire/ -- New secondary analysis from Eli Lilly and Companys (NYSE: LLY) Phase 3 clinical development program showed patients receiving lebrikizumab who...

United Kingdom New York United States Karl Ziegelbauer Joe Fletcher Rachel Hoffmeyer

Source: prnewswire.com

Almirall: Up to 73% of Atopic Dermatitis Patients Taking Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

May 1, 2023

Almirall S.A. today announced results from a new secondary analysis from the Phase 3 clinical development program which showed patients receiving lebrikizumab who were assessed at 16 weeks... | May 1, 2023

United Kingdom New York United States Comunidad Autonoma De Cataluna Karl Ziegelbauer Eli Lilly

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Cleared Face News Today

Up to 73% of Atopic Dermatitis Patients Taking Lilly's Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

Almirall: Up to 73% of Atopic Dermatitis Patients Taking Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

Explore More Categories